InfuSystem Holdings (INFU) Capital Expenditures Growth (3y) (2013 - 2026)
InfuSystem Holdings (INFU) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -0.66% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 9.94% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.89% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.78% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 12.81% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 12.62% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 19.51% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 9.52% |
| 10 | InfuSystem Holdings | 244.67 Mn | 243.70 Mn | 21.41 Mn | -27.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27.75% |
| Mar 31, 2026 | -20.88% |
| Dec 31, 2025 | 26.07% |
| Sep 30, 2025 | -47.69% |
| Jun 30, 2025 | 270.73% |
| Mar 31, 2025 | -170.45% |
| Dec 31, 2024 | -43.08% |
| Sep 30, 2024 | -92.54% |
| Jun 30, 2024 | 44.93% |
| Mar 31, 2024 | -125.06% |
| Dec 31, 2023 | -212.58% |
| Sep 30, 2023 | 73.22% |
| Jun 30, 2023 | 5.44% |
| Mar 31, 2023 | -15.69% |
| Dec 31, 2022 | -20.00% |
| Sep 30, 2022 | 170.14% |
| Jun 30, 2022 | 81.06% |
| Mar 31, 2022 | -77.36% |
| Dec 31, 2021 | 30.20% |
| Sep 30, 2021 | -28.67% |